Details about Andrea Marcellusi

Access statistics for papers by Andrea Marcellusi.

Last updated 2019-05-21. Update your information in the RePEc Author Service.

Short-id: pma2581

Working Papers

2016

1. Early treatment in HCV: is it a cost-effective option from the Italian perspective?
   CEIS Research Paper, Tor Vergata University, CEIS View citations (2)

2015

2. Cost of poor adherence to anti-hypertensive therapy in five European countries
   Post-Print, HAL View citations (3)
   See also Journal Article Cost of poor adherence to anti-hypertensive therapy in five European countries, The European Journal of Health Economics, Springer (2015) View citations (2) (2015)
3. Treatment Plan Comparison in Obstructive Respiratory Disorders: an Observational Study of Doxofylline vs. Theophylline in the Marche Region
   CEIS Research Paper, Tor Vergata University, CEIS

2014

4. Direct and Indirect Cost of Diabetes in Italy: a Prevalence Probabilistic Approach
   CEIS Research Paper, Tor Vergata University, CEIS
   See also Journal Article The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach, The European Journal of Health Economics, Springer (2016) View citations (10) (2016)
5. Health Policy Model: Long-term Predictive Results Associated With The Management Of HCV-Induced Diseases In Italy
   CEIS Research Paper, Tor Vergata University, CEIS View citations (3)

2013

6. Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe
   CEIS Research Paper, Tor Vergata University, CEIS
7. Economic effects of treatment of chronic kidney disease with low-protein diet
   CEIS Research Paper, Tor Vergata University, CEIS View citations (1)

Journal Articles

2019

1. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data
   PharmacoEconomics, 2019, 37, (2), 255-266

2017

2. The perception of corruption in health: AutoCM methods for an international comparison
   Quality & Quantity: International Journal of Methodology, 2017, 51, (1), 459-477 View citations (2)

2016

3. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach
   The European Journal of Health Economics, 2016, 17, (2), 139-147 View citations (10)
   See also Working Paper Direct and Indirect Cost of Diabetes in Italy: a Prevalence Probabilistic Approach, CEIS Research Paper (2014) (2014)

2015

4. Cost of poor adherence to anti-hypertensive therapy in five European countries
   The European Journal of Health Economics, 2015, 16, (1), 65-72 View citations (2)
   See also Working Paper Cost of poor adherence to anti-hypertensive therapy in five European countries, Post-Print (2015) View citations (3) (2015)
5. Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country
   The European Journal of Health Economics, 2015, 16, (8), 909-911 View citations (2)